Abpro Holdings (ABPO) Tax Provisions (2022 - 2024)
Abpro Holdings' (ABPO) quarterly Tax Provisions came in at $27654.0 in Q3 2024, down 71.2% YoY from $96005.0 in Q4 2023, and up 5.66% on a QoQ basis from $26173.0 in Q2 2024.
Abpro Holdings (ABPO) Tax Provisions (2022 - 2024) Analysis & Trends
Abpro Holdings (ABPO) has 3 years of Tax Provisions data on file, last reported at $27654.0 in Q3 2024.
- Quarterly Tax Provisions fell 71.2% year-over-year to $27654.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $141784.0 (down 91.27% YoY) and the FY2023 annual result came in at $1.2 million, up 42.9% from the prior year.
- Tax Provisions advanced to $27654.0 in Q3 2024, from $26173.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $679998.0 in Q1 2023 to a low of $4140.0 in Q1 2024.
- A 3-year average of $205942.1 and a median of $89911.0 in 2023 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2023 — Tax Provisions surged 4848.48% — and 2024, when it plunged 99.39%.
- Tracing ABPO's Tax Provisions over 3 years: stood at $530538.0 in 2022, then slumped by 84.2% to $83817.0 in 2023, then sank by 67.01% to $27654.0 in 2024.
- The last three Tax Provisions figures came in at $27654.0 (Q3 2024), $26173.0 (Q2 2024), and $4140.0 (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 13.31 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.90 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Abpro Holdings | 1.14 Mn | 1.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 27,654.00 |
| Jun 30, 2024 | 26,173.00 |
| Mar 31, 2024 | 4,140.00 |
| Dec 31, 2023 | 83,817.00 |
| Sep 30, 2023 | 96,005.00 |
| Jun 30, 2023 | 317,643.00 |
| Mar 31, 2023 | 679,998.00 |
| Dec 31, 2022 | 530,538.00 |
| Sep 30, 2022 | 287,034.00 |
| Jun 30, 2022 | 6,419.00 |